Volume guarantee versus high-frequency ventilation: lung inflammation in preterm infants.

@article{Lista2008VolumeGV,
  title={Volume guarantee versus high-frequency ventilation: lung inflammation in preterm infants.},
  author={Gianluca Lista and Francesca Castoldi and Silvia Bianchi and M Battaglioli and Francesco Cavigioli and Mariangela Bosoni},
  journal={Archives of disease in childhood. Fetal and neonatal edition},
  year={2008},
  volume={93 4},
  pages={F252-6}
}
BACKGROUND Appropriate ventilation together with improvement of clinical care of premature babies can contribute to reducing lung inflammation, known to represent the "primum movens" of bronchopulmonary dysplasia (BPD). High-frequency oscillatory ventilation (HFOV) and volume-guarantee (VG) ventilation are effective in the treatment of neonatal respiratory distress syndrome (RDS). OBJECTIVE To assess the potential of HFOV and VG to prevent BPD in the acute phase of RDS, by a randomised… CONTINUE READING

Connections & Topics

Mentioned Connections BETA
Appropriate ventilation together with improvement of clinical care of premature babies can contribute to reducing lung inflammation , known to represent the " primum movens " of bronchopulmonary dysplasia ( BPD ) .
Appropriate ventilation together with improvement of clinical care of premature babies can contribute to reducing lung inflammation , known to represent the " primum movens " of bronchopulmonary dysplasia ( BPD ) .
Appropriate ventilation together with improvement of clinical care of premature babies can contribute to reducing lung inflammation , known to represent the " primum movens " of bronchopulmonary dysplasia ( BPD ) .
Appropriate ventilation together with improvement of clinical care of premature babies can contribute to reducing lung inflammation , known to represent the " primum movens " of bronchopulmonary dysplasia ( BPD ) .
Levels of interleukin ( IL ) 6 , IL8 and tumour necrosis factor were determined in tracheal aspirate on days 1 , 3 and 7 of life .
Levels of interleukin ( IL ) 6 , IL8 and tumour necrosis factor were determined in tracheal aspirate on days 1 , 3 and 7 of life .
Levels of interleukin ( IL ) 6 , IL8 and tumour necrosis factor were determined in tracheal aspirate on days 1 , 3 and 7 of life .
Forty infants ( gestational age 25 - 32 weeks ) with RDS were assigned to assist - control ventilation plus VG ( Vt = 5 ml / kg ) or HFOV ( both with a Dräger Babylog 8000 plus ventilator ) .
Levels of interleukin ( IL ) 6 , IL8 and tumour necrosis factor were determined in tracheal aspirate on days 1 , 3 and 7 of life .
Levels of interleukin ( IL ) 6 , IL8 and tumour necrosis factor were determined in tracheal aspirate on days 1 , 3 and 7 of life .
Forty infants ( gestational age 25 - 32 weeks ) with RDS were assigned to assist - control ventilation plus VG ( Vt = 5 ml / kg ) or HFOV ( both with a Dräger Babylog 8000 plus ventilator ) .
All Topics